Comparison Overview

UCB

VS

Merck

UCB

Allée de la Recherche, 60, Brussels, BE
Last Update: 2025-12-10
View Profile
Between 800 and 849
http://www.ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. We act with thoughtful intent to ensure our work reflects the voices of those we serve. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 12,309
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Merck

126 E Lincoln Ave, P.O. Box 2000, Rahway, New Jersey, US, 07065
Last Update: 2025-12-09
Between 800 and 849
http://merck.us/2J2xAUh

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 42,297
Subsidiaries: 2
12-month incidents
1
Known data breaches
1
Attack type number
2

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/ucb-pharma.jpeg
UCB
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/merck.jpeg
Merck
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
UCB
100%
Compliance Rate
0/4 Standards Verified
Merck
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for UCB in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

Merck has 25.0% more incidents than the average of same-industry companies with at least one recorded incident.

Incident History — UCB (X = Date, Y = Severity)

UCB cyber incidents detection timeline including parent company and subsidiaries

Incident History — Merck (X = Date, Y = Severity)

Merck cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/ucb-pharma.jpeg
UCB
Incidents

No Incident

https://images.rankiteo.com/companyimages/merck.jpeg
Merck
Incidents

Date Detected: 9/2025
Type:Breach
Blog: Blog

Date Detected: 06/2017
Type:Cyber Attack
Blog: Blog

FAQ

UCB company demonstrates a stronger AI Cybersecurity Score compared to Merck company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Merck company has historically faced a number of disclosed cyber incidents, whereas UCB company has not reported any.

In the current year, Merck company has reported more cyber incidents than UCB company.

Neither Merck company nor UCB company has reported experiencing a ransomware attack publicly.

Merck company has disclosed at least one data breach, while UCB company has not reported such incidents publicly.

Merck company has reported targeted cyberattacks, while UCB company has not reported such incidents publicly.

Neither UCB company nor Merck company has reported experiencing or disclosing vulnerabilities publicly.

Neither UCB nor Merck holds any compliance certifications.

Neither company holds any compliance certifications.

Merck company has more subsidiaries worldwide compared to UCB company.

Merck company employs more people globally than UCB company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither UCB nor Merck holds SOC 2 Type 1 certification.

Neither UCB nor Merck holds SOC 2 Type 2 certification.

Neither UCB nor Merck holds ISO 27001 certification.

Neither UCB nor Merck holds PCI DSS certification.

Neither UCB nor Merck holds HIPAA certification.

Neither UCB nor Merck holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, there is no handler for JSON parsing errors; SyntaxError from express.json() includes user input in the error message, which gets reflected in responses. User input (including HTML/JavaScript) can be exposed in error responses, creating an XSS risk if Content-Type isn't strictly enforced. This issue does not have a fix at the time of publication.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when creating prompts, JSON requests are sent to define and modify the prompts via PATCH endpoint for prompt groups (/api/prompts/groups/:groupId). However, the request bodies are not sufficiently validated for proper input, enabling users to modify prompts in a way that was not intended as part of the front end system. The patchPromptGroup function passes req.body directly to updatePromptGroup() without filtering sensitive fields. This issue is fixed in version 0.8.1.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when a user posts a question, the iconURL parameter of the POST request can be modified by an attacker. The malicious code is then stored in the chat which can then be shared to other users. When sharing chats with a potentially malicious “tracker”, resources loaded can lead to loss of privacy for users who view the chat link that is sent to them. This issue is fixed in version 0.8.1.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

MaxKB is an open-source AI assistant for enterprise. Versions 2.3.1 and below have improper file permissions which allow attackers to overwrite the built-in dynamic linker and other critical files, potentially resulting in privilege escalation. This issue is fixed in version 2.4.0.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References
Description

MaxKB is an open-source AI assistant for enterprise. In versions 2.3.1 and below, the tool module allows an attacker to escape the sandbox environment and escalate privileges under certain concurrent conditions. This issue is fixed in version 2.4.0.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References